For example, Wang et al. demonstrated that VEGF was most closely related to brain inflammation during the COVID-19 outbreak and therefore could be a potential therapeutic target for SARS-CoV-2 patients with neurological symptoms (108). Here, VEGFA is linked to inflammation.